Alcohol intake and risk of non-Hodgkin lymphoma in men and women
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Objective: The effect of alcohol intake on risk of NHL is unclear. We therefore conducted a population-based case-control study to examine the association between alcohol and NHL risk.
Methods: 613 NHL cases and 480 population controls in Sweden reported their average consumption of beer, wine, and liquor 2 years before the study. Unconditional logistic regression was used to estimate the odds ratios (OR) and corresponding 95% confidence intervals (CI) for associations between alcohol intake and NHL risk.
Results: Intake of total alcohol, beer, wine, or liquor was not associated with risk of overall NHL. There was no difference in risk of NHL among those who habitually consumed above 19.1 g of ethanol per day, compared to those who consumed on average 0–2.2 g of ethanol per day (OR = 1.2 (95% CI: 0.8, 1.7); p trend = 0.29). However, the association was significantly positive among males (OR = 1.8 (95% CI: 1.1, 2.9); p trend = 0.06). Total alcohol, beer, wine, or liquor intake was not associated with any major histopathologic subtype of NHL examined, apart from an association between high wine consumption and increased risk of chronic lymphocytic leukemia.
Conclusions: Alcohol does not appear to be a major etiologic factor for overall NHL, nor its common subtypes.
- Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system–a review. Alcoholism: Clin Exp Res 22 (9): 1927–1942.
- Diaz LE, Montero A, Gonzalez-Gross M, Vallejo AI, Romeo J, Marcos A (2002) Influence of alcohol consumption on immuno-logical status: a review. Eur J Clin Nut 56 (Suppl 3): S50–S53.
- Szabo G (1999) Consequences of alcohol consumption on host defence. Alcohol Alcohol 34 (6): 830–841.
- Filipovich AH, Mathur A, Kamat D, Shapiro RS (1992) Primary immunode ciencies: genetic risk factors for lymphoma. Cancer Res 52 (Suppl 19): 5465s–5467s.
- Hoover RN (1992) Lymphoma risks in populations with altered immunity–a search for mechanism. Cancer Res 52 (Suppl 19): 5477s–5478s.
- Levine AM (1994) Lymphoma complicating immunode ciency disorders. Ann Oncol 5 (Suppl 2): 29–35.
- Morton LM, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, et al. (2003) Alcohol use and risk of non-Hodgkin 's lymphoma among Connecticut women (United States). Cancer Causes Control 14 (7): 687–694.
- Briggs NC, Levine RS, Bobo LD, Haliburton WP, Brann EA, Hennekens CH (2002) Wine drinking and risk of non-Hodgkin 's lymphoma among men in the United States: a population-based case-control study. Am J Epidemiol 156 (5): 454–462.
- Brown LM, Gibson R, Burmeister LF, Schuman LM, Everett GD, Blair A (1992) Alcohol consumption and risk of leukemia, non-Hodgkin 's lymphoma, and multiple myeloma. Leuk Res 16 (10): 979–984.
- Chiu BC, Cerhan JR, Gapstur SM, Sellers TA, Zheng W, Lutz CT, et al. (1999) Alcohol consumption and non-Hodgkin lymphoma in a cohort of older women. Br J Cancer 80 (9): 1476–1482.
- Chiu BC, Weisenburger DD, Cantor KP, Zahm SH, Holmes F, Burmeister LF, et al. (2002) Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodg-kin 's lymphoma in men. Ann Epidemiol 12 (5): 309–315.
- De Stefani E, Fierro L, Barrios E, Ronco A (1998) Tobacco, alcohol, diet and risk of non-Hodgkin 's lymphoma: a case-control study in Uruguay. Leuk Res 22 (5): 445–452.
- Kato I, Nomura AM, Stemmermann GN, Chyou PH (1992) Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites. Cancer Causes Control 3 (2): 145–151.
- Nelson RA, Levine AM, Marks G, Bernstein L (1997) Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin 's lymphoma. Br J Cancer 76 (11): 1532–1537.
- Tavani A, Gallus S, La Vecchia C, Franceschi S (2001) Alcohol drinking and risk of non-Hodgkin 's lymphoma. Eur J Clin Nutr 55 (10): 824–826.
- Cartwright RA, McKinney PA, O'Brien C, Richards ID, Roberts B, Lauder I, et al. (1988) Non-Hodgkin 's lymphoma: case control epidemiological study in Yorkshire. Leuk Res 12 (1): 81–88.
- Franceschi S, Serraino D, Carbone A, Talamini R, La Vecchia C (1989) Dietary factors and non-Hodgkin 's lymphoma: a case-control study in the northeastern part of Italy. Nutr Cancer 12 (4): 333–341.
- Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case-control study of non-Hodgkin 's lymphoma among women and heterosex-ual men in the San Francisco Bay Area, California. Am J Epidemiol 150 (4): 375–389.
- Nordström M (1996) Increasing incidence of non-Hodgkin 's lymphomas in Sweden 1958–1992. Oncol Rep 3: 645–649.
- Rabkin CS, Devesa SS, Zahm SH, Gail MH (1993) Increasing incidence of non-Hodgkin 's lymphoma. Semin Hematol 30 (4): 286–296.
- National Board of Health and Welfare. Cancer Incidence in Sweden (1990). Stockholm: National Board of Health and Welfare, Centre for Epidemiology, Official Statistics of Sweden; (1990).
- Vose JM, Chiu BC, Cheson BD, Dancey J, Wright J (2002) Update on epidemiology and therapeutics for non-Hodgkin 's lymphoma. Hematol (Am Soc Hematol Educ Program) 241–262.
- Banks PM (1992) Changes in diagnosis of non-Hodgkin 's lym-phomas over time. Cancer Res 52 (Suppl 19): 5453s–5455s.
- Hartge P, Devesa SS (1992) Quanti cation of the impact of known risk factors on time trends in non-Hodgkin 's lymphoma incidence. Cancer Res 52 (Suppl 19)&: 5566s–5569s
- Obrams GI, O'Conor G (1992) The emerging epidemic of non-Hodgkin 's lymphoma: current knowledge regarding etiological factors. Time trends and pathological Classification: a summary. Cancer Res 52 (Suppl 19)&: 557
- Jaffe ES, Harris NL, Stein H, Vardiman JW (eds)(2001) WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: Interna-tional Agency for Research on Cancer (IARC)Press.
- International Statistical Classification of Diseases and Related Health Problems, 1989 Revision. Geneva: World Health Organi-zation (1992).
- Swedish Cancer Register. Cancer Incidence in Sweden 1998. Stockholm: Centre for Epidemiology (2000).
- Maldonado G, Greenland S (1993) Simulation study of con-founder-selection strategies. Am J Epidemiol 138 (11): 923–936.
- Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system–a review. Alcoholism: Clin Exp Res 22 (9)&: 1927–19
- Watzl B, Bub A, Briviba K, Rechkemmer G (2002) Acute intake of moderate amounts of red wine or alcohol has no effect on the immune system of healthy men. Eur J Nut 41 (6): 264–270.
- Bounds W, Betzing KW, Stewart RM, Holcombe RF (1994) Social drinking and the immune response: impairment of lymphokine-activated killer activity. Am J Med Sci 307 (6): 391–395.
- Schuurs AH, Verheul HA (1990) Effects of gender and sex steroids on the immune response. J Steroid Biochem 35 (2): 157–172.
- Kovacs EJ, Messingham KA (2002) In. uence of alcohol and gender on immune response. Alcohol Research Health: J Natl Inst Alcohol Abuse Alcohol 26 (4): 257–263.
- Bergman H, Kallmen H (2002) Alcohol use among Swedes and a psychometric evaluation of the alcohol use disorders identification test. Alcohol Alcohol 37 (3): 245–251.
- Alcohol intake and risk of non-Hodgkin lymphoma in men and women
Cancer Causes & Control
Volume 15, Issue 10 , pp 1067-1076
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- non-Hodgkin lymphoma
- Industry Sectors
- Author Affiliations
- 1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, Stockholm, SE-171 77, Sweden
- 2. Division of Preventive Medicine, Department of Medicine, Department of Epidemiology, Brigham and Women's Hospital and Harvard Medical School, Harvard School of Public Health, Boston, MA, USA
- 3. Department of Epidemiology Researchn, Statens Serum Institut, Copenhagen, Denmark
- 4. Department of Pathology and Cytology, Medilab, Stockholm, Sweden
- 5. Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 6. Department of Oncology, Radiology and Clinical Immunology, Department of Oncology and Pathology, University of Uppsala, Karolinska Institutet, Uppsala, Stockholm, Sweden